With more than 1.9 million new cancer cases expected to be diagnosed in the U.S. in 2023, according to the American Cancer Society (ACS), screenings are critical to detect the disease in its early ...

The recent approval of teplizumab-mzwv (Tzield, Provention Bio) for the delay of type 1 diabetes by the US Food and Drug Administration is expected to advance efforts to increase screening to ...

(WXYZ) — November is Diabetes Awareness Month; it’s a disease that affects millions of people across the United States – both with type one and type two. Type ...

Please provide your email address to receive an email when new articles are posted on . The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to ...

Oct. 31, 2024 -- Type 1 diabetes can develop at any age, making early screening crucial for those at risk. But how do we know who is at risk? When should we screen? And what steps can we take to ...

Note: This review article focuses on cancer screening guidelines for average-risk individuals. Each professional organization uniquely evaluates the evidence base, and we are reporting guidelines with ...

The time has come for universal screening, but we still need to resolve certain issues. A few months ago, I would have questioned the value of universal screening for type 1 diabetes because we did ...

According to the American Cancer Society, colorectal cancer is one of the leading causes of cancer in men and women.

The U.S. Preventive Services Task Force has recommended lowering the age to start screening for prediabetes and Type 2 diabetes among obese or overweight adults by five years, to age 35. "Clinicians ...

After 100 years of insulin therapy, teplizumab, an immunotherapy for early-stage type 1 diabetes, has been approved for the first time in the United States and has been shown to delay the ...